{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:27:12Z","timestamp":1784388432190,"version":"3.55.0"},"reference-count":35,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/501100006706","name":"Tampere Tuberculosis Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008309","name":"Research Foundation of the Pulmonary Diseases","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100008309","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Finnish Anti-Tuberculosis Association Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Allergy Research Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Medical Research Fund of Sein\u00e4joki Central Hospital","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Nummela Sanatorium Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Nordic Council\/NordForsk","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,11,15]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Nonsteroidal anti-inflammatory drugs (NSAIDs) may exacerbate respiratory symptoms. A recent European Academy of Allergy and Clinical Immunology position paper recommended the use of an acronym, N-ERD (NSAID-exacerbated respiratory disease), for this hypersensitivity associated with asthma or chronic rhinosinusitis with or without nasal polyposis. Our aim was to estimate the prevalence of N-ERD and identify factors associated with N-ERD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In 2016, a cross-sectional questionnaire survey of a random adult population of 16\u200a000 subjects aged 20\u201369\u2005years was performed in Helsinki and Western Finland. The response rate was 51.5%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence was 1.4% for N-ERD, and 0.7% for aspirin-exacerbated respiratory disease (AERD). The prevalence of N-ERD was 6.9% among subjects with asthma and 2.7% among subjects with rhinitis. The risk factors for N-ERD were older age, family history of asthma or allergic rhinitis, long-term smoking and exposure to environmental pollutants. Asthmatic subjects with N-ERD had a higher risk of respiratory symptoms, severe hypersensitivity reactions and hospitalisations than asthmatic subjects without N-ERD. The subphenotype of N-ERD with asthma was most symptomatic. Subjects with rhinitis associated with N-ERD, which would not be included in AERD, had the fewest symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We conclude that the prevalence of N-ERD was 1.4% in a representative Finnish adult population sample. Older age, family history of asthma or allergic rhinitis, cumulative exposure to tobacco smoke, secondhand smoke, and occupational exposures increased odds of N-ERD. N-ERD was associated with significant morbidity.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00462-2021","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T12:45:16Z","timestamp":1642077916000},"page":"00462-2021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["NSAID-exacerbated respiratory disease: a population study"],"prefix":"10.1183","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5923-5865","authenticated-orcid":false,"given":"Heidi","family":"Anders\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8758-2431","authenticated-orcid":false,"given":"Pinja","family":"Ilmarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Honkam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6990-4508","authenticated-orcid":false,"given":"Leena E.","family":"Tuomisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Hisinger-M\u00f6lk\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0553-8067","authenticated-orcid":false,"given":"Helena","family":"Backman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lundb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2358-8754","authenticated-orcid":false,"given":"Eva","family":"R\u00f6nmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari","family":"Haahtela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anssi","family":"Sovij\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Piiril\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Kankaanranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"2024101711254973000_8.1.00462-2021.1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-68-5-975"},{"key":"2024101711254973000_8.1.00462-2021.2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD) \u2013 a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"2024101711254973000_8.1.00462-2021.3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2016.11.023","article-title":"Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease","volume":"140","author":"Eastman","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2024101711254973000_8.1.00462-2021.4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s40629-018-0064-0","article-title":"NSAID hypersensitivity \u2013 recommendations for diagnostic work up and patient management","volume":"27","author":"W\u00f6hrl","year":"2018","journal-title":"Allergo J Int"},{"key":"2024101711254973000_8.1.00462-2021.5","doi-asserted-by":"crossref","first-page":"16710","DOI":"10.1038\/s41598-018-34668-1","article-title":"NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs","volume":"8","author":"Do\u00f1a","year":"2018","journal-title":"Sci Rep"},{"key":"2024101711254973000_8.1.00462-2021.6","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/all.12941","article-title":"Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA2LEN) survey","volume":"71","author":"Makowska","year":"2016","journal-title":"Allergy"},{"key":"2024101711254973000_8.1.00462-2021.7","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/28.4.717"},{"key":"2024101711254973000_8.1.00462-2021.8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/cea.12359","article-title":"Aspirin-intolerant asthma in the population: prevalence and important determinants","volume":"45","author":"Eriksson","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"2024101711254973000_8.1.00462-2021.9","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00267.x"},{"key":"2024101711254973000_8.1.00462-2021.10","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.7.569"},{"key":"2024101711254973000_8.1.00462-2021.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.08.020"},{"key":"2024101711254973000_8.1.00462-2021.12","doi-asserted-by":"publisher","DOI":"10.1111\/all.12629"},{"key":"2024101711254973000_8.1.00462-2021.13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.aller.2011.05.015","article-title":"Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey","volume":"40","author":"Bavbek","year":"2012","journal-title":"Allergol Immunopathol"},{"key":"2024101711254973000_8.1.00462-2021.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62084-4"},{"key":"2024101711254973000_8.1.00462-2021.15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.anai.2011.09.022","article-title":"Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease","volume":"108","author":"Chang","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2024101711254973000_8.1.00462-2021.16","doi-asserted-by":"crossref","first-page":"31024","DOI":"10.3402\/ecrj.v3.31024","article-title":"Respiratory symptoms increase health care consumption and affect everyday life \u2013 a cross-sectional population-based study from Finland, Estonia, and Sweden","volume":"3","author":"Axelsson","year":"2016","journal-title":"Eur Clin Respir J"},{"key":"2024101711254973000_8.1.00462-2021.17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rmed.2019.07.014","article-title":"The increase of asthma prevalence has levelled off and symptoms decreased in adults during 20\u2005years from 1996 to 2016 in Helsinki, Finland","volume":"155","author":"Hisinger-M\u00f6lk\u00e4nen","year":"2019","journal-title":"Respir Med"},{"key":"2024101711254973000_8.1.00462-2021.18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rmed.2019.06.003","article-title":"Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood","volume":"154","author":"Honkam\u00e4ki","year":"2019","journal-title":"Respir Med"},{"key":"2024101711254973000_8.1.00462-2021.19","doi-asserted-by":"crossref","first-page":"106017","DOI":"10.1016\/j.rmed.2020.106017","article-title":"Non-response did not affect prevalence estimates of asthma and respiratory symptoms \u2013 results from a postal questionnaire survey of the general population","volume":"173","author":"R\u00e4is\u00e4nen","year":"2020","journal-title":"Respir Med"},{"key":"2024101711254973000_8.1.00462-2021.20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.iac.2016.06.010","article-title":"Genetic and epigenetic components of aspirin-exacerbated respiratory disease","volume":"36","author":"Dahlin","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"2024101711254973000_8.1.00462-2021.21","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/all.14177","article-title":"The need for clean air: the way air pollution and climate change affect allergic rhinitis and asthma","volume":"75","author":"Eguiluz-Gracia","year":"2020","journal-title":"Allergy"},{"key":"2024101711254973000_8.1.00462-2021.22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/WOX.0b013e3181ecd8ae","article-title":"Staphylococcus aureus and chronic airway disease","volume":"3","author":"Derycke","year":"2010","journal-title":"World Allergy Organ J"},{"key":"2024101711254973000_8.1.00462-2021.23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2147\/JAA.S323504","article-title":"Influence of childhood exposure to a farming environment on age at asthma diagnosis in a population-based study","volume":"14","author":"Anders\u00e9n","year":"2021","journal-title":"J Asthma Allergy"},{"key":"2024101711254973000_8.1.00462-2021.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.07.024"},{"key":"2024101711254973000_8.1.00462-2021.25","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600"},{"key":"2024101711254973000_8.1.00462-2021.26","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.016003432.x"},{"key":"2024101711254973000_8.1.00462-2021.27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024101711254973000_8.1.00462-2021.28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2024101711254973000_8.1.00462-2021.29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1164\/rccm.201904-0716ED","article-title":"Aspirin-exacerbated respiratory disease: a syndrome of mast cell-mediated PgD2 overproduction","volume":"200","author":"Borish","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711254973000_8.1.00462-2021.30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/all.13075","article-title":"Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease","volume":"72","author":"Lee","year":"2017","journal-title":"Allergy"},{"key":"2024101711254973000_8.1.00462-2021.31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaci.2018.10.007","article-title":"Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease","volume":"143","author":"Cahill","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2024101711254973000_8.1.00462-2021.32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-019-1040-2","article-title":"Age-specific incidence of allergic and non-allergic asthma","volume":"20","author":"Pakkasela","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2024101711254973000_8.1.00462-2021.33","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.chest.2017.07.033","article-title":"Anaphylaxis","volume":"153","author":"LoVerde","year":"2018","journal-title":"Chest"},{"key":"2024101711254973000_8.1.00462-2021.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.08.035"},{"key":"2024101711254973000_8.1.00462-2021.35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1403494817725243","article-title":"Language as a determinant of participation rates in Finnish health examination surveys","volume":"46","author":"Tolonen","year":"2018","journal-title":"Scand J Public Health"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00462-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:13:37Z","timestamp":1740374017000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00462-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,24]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1183\/23120541.00462-2021"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00462-2021","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}